7.8 C
London
Thursday, December 12, 2024
HomeNewsL'Oréal Acquires 10% Stake in Swiss Dermatology Company Galderma

L’Oréal Acquires 10% Stake in Swiss Dermatology Company Galderma

Date:

Related stories

Gazprom Maintains Stable Gas Deliveries to Europe, Sending 42.3 Million m³ on Monday

Brussels, October 14 (FinanceFlashNews.com) – Gazprom, Russia’s gas producer,...

Markets Anticipate Faster ECB Rate Cuts as Eurozone Inflation Falls

Frankfurt, October 14 (FinanceFlashNews.com) – Financial markets are predicting...

Tax Hike in France Will Hurt Investments, Warns Stellantis CEO

Paris, October 14 (FinanceFlashNews.com) – The French government's plan...

Finland’s Inflation Drops to Lowest Level in Nearly Four Years

Helsinki, October 14 (FinanceFlashNews.com) – Year-on-year inflation in Finland...

Moody’s Downgrades Belgium’s Credit Outlook to Negative

Brussels, October 13 (FinanceFlashNews.com) – Moody's Ratings downgraded Belgium’s...

Key Takeaways:

  • L’Oréal’s acquisition of a 10% stake in Galderma marks its re-entry into the dermatological market.
  • This move will provide L’Oréal with access to the growing market for injectable cosmetics.
  • The acquisition is part of L’Oréal’s strategy to expand its product portfolio and target new consumer segments.

Bern/Paris, August 5 (FinanceFlashNews) – French cosmetics giant L’Oréal has acquired a 10% stake in Swiss-based Galderma, a company specializing in dermatological products. This move will provide the French company with greater access to the lucrative injectable cosmetics market.

Galderma was originally a joint venture between L’Oréal and Swiss food giant Nestlé. However, the French company sold its 50% stake to Nestlé in the summer of 2014. Five years later, investors purchased Galderma from Nestlé.

L’Oréal will now acquire a 10% stake in Galderma from a consortium led by Swedish investment firm EQT, along with the Abu Dhabi Investment Authority (ADIA) and Auba Investment. While the value of the deal has not been disclosed, based on Friday’s closing price, the market value of the stake is estimated at 1.6 billion Swiss francs (1.7 billion euros).

Although this stake represents a small portion of the sixth-largest cosmetics company in Europe, it will allow L’Oréal to tap into the lucrative and rapidly growing market for injectable anti-wrinkle products, such as Botox.

Financeflashnewshttps://financeflashnews.com
This article was written by the editorial team of Financeflashnews. We strive to provide you with accurate and up-to-date information from the world of finance and investment. If you find any errors in the article, please let us know at corrections@financeflashnews.com. Your feedback is valuable to us and will help us improve the quality of our content.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories